[go: up one dir, main page]

NO983453D0 - Procedure for increasing sphincter function - Google Patents

Procedure for increasing sphincter function

Info

Publication number
NO983453D0
NO983453D0 NO983453A NO983453A NO983453D0 NO 983453 D0 NO983453 D0 NO 983453D0 NO 983453 A NO983453 A NO 983453A NO 983453 A NO983453 A NO 983453A NO 983453 D0 NO983453 D0 NO 983453D0
Authority
NO
Norway
Prior art keywords
procedure
sphincter function
increasing sphincter
increasing
function
Prior art date
Application number
NO983453A
Other languages
Norwegian (no)
Other versions
NO983453L (en
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603147.1A external-priority patent/GB9603147D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO983453D0 publication Critical patent/NO983453D0/en
Publication of NO983453L publication Critical patent/NO983453L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO983453A 1996-01-29 1998-07-27 Procedures for increasing sphincter function NO983453L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077196P 1996-01-29 1996-01-29
GBGB9603147.1A GB9603147D0 (en) 1996-02-15 1996-02-15 Methods of increasing sphincter competence
PCT/US1997/001159 WO1997026876A1 (en) 1996-01-29 1997-01-27 Methods of increasing sphincter competence

Publications (2)

Publication Number Publication Date
NO983453D0 true NO983453D0 (en) 1998-07-27
NO983453L NO983453L (en) 1998-09-11

Family

ID=26308706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983453A NO983453L (en) 1996-01-29 1998-07-27 Procedures for increasing sphincter function

Country Status (11)

Country Link
EP (1) EP0910378A4 (en)
JP (1) JP2000503991A (en)
CN (1) CN1213303A (en)
AU (1) AU732473B2 (en)
CZ (1) CZ235598A3 (en)
EA (1) EA001103B1 (en)
HU (1) HUP9903440A3 (en)
IL (1) IL125522A0 (en)
NO (1) NO983453L (en)
NZ (1) NZ331085A (en)
WO (1) WO1997026876A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113007A1 (en) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
AU2001271781A1 (en) * 2000-07-06 2002-01-21 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
US20040248989A1 (en) * 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
JP5123935B2 (en) 2006-05-22 2013-01-23 ホルモス メディカル リミテッド Method for treating chronic non-bacterial prostatitis using selective estrogen receptor modulators or aromatase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
AU3899595A (en) * 1994-12-02 1996-06-19 Mostyn Farmer Golf stance training aid
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

Also Published As

Publication number Publication date
EP0910378A1 (en) 1999-04-28
HUP9903440A2 (en) 2000-06-28
CZ235598A3 (en) 1999-03-17
EP0910378A4 (en) 1999-06-23
HUP9903440A3 (en) 2000-07-28
EA001103B1 (en) 2000-10-30
EA199800676A1 (en) 1999-02-25
AU732473B2 (en) 2001-04-26
CN1213303A (en) 1999-04-07
NZ331085A (en) 2000-06-23
WO1997026876A1 (en) 1997-07-31
AU1838697A (en) 1997-08-20
JP2000503991A (en) 2000-04-04
NO983453L (en) 1998-09-11
IL125522A0 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
FI960525A0 (en) Framstaellning av mellandestillat
FI961551A0 (en) Menylett utforming av kortmeddelanden
FI962166A0 (en) Foerfarande Foer festaemmande av utbredningsdaempning av radiovaogor
NO983453D0 (en) Procedure for increasing sphincter function
FI960501A0 (en) Foerfarande Foer omkastning av uppkopplingsriktningen av samtal
FI961041A0 (en) Klingledare av saogmaskin
FI960962A0 (en) Foerfarande Foer framstaellning av en flerskiktskartongprofil
FI962427A0 (en) Placering av suptunnor under jorden
FI961102A0 (en) Foerfarande Foer vidarebefordring av Elektroniska postmeddelanden till en traodtelefonabonnent
FI960457A0 (en) Placering av ovanpao varandra staplade containrar i en jaernvaegsvagn
FI960294A0 (en) Redskap Foer borrning av haol i riktning uppaot
FI964701A0 (en) Utnyttjande av faerger i datakommunikationsteknik
FI961733A0 (en) Anordning Foer sortering av virke
FI961474A0 (en) Foerfarande Foer stegloes bearbetning av signalen
FI962663A0 (en) Foerfarande Foer maetning av haerdningsgrad
FI962635A0 (en) Anordningar Foer behandling av avfall
FI962903A0 (en) Foerfarande Foer kombinering av en maongsidig avfallsbehandlingsanlaeggning
FI962524A0 (en) Foerpackning Foer postning av platta foeremaol
FI962430A0 (en) Traeningsredskap saerskilt Foer utvecklande av Foer ishockey typiska grenegenskaper
FI962175A0 (en) Skivtrumsikt Foer siktning av jord-material
FI962119A0 (en) Anordning oefr uppvaermning av babymjoelk
FI962023A0 (en) Foerfarande Foer toemning av en foervaringspaerm
FI961973A0 (en) Anordning Foer bearbetning av skogsmark
FI961878A0 (en) Foerfarande Foer framstaellning av plastprodukter
FI962687A0 (en) Foerfarande Foerfurande Foer berikning av biologiskt aktiva proteininer fraon vassla av raomjoelk

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application